Log in
Enquire now
‌

US Patent 9630929 Benzenesulfonamide compounds and their use as therapeutic agents

Patent 9630929 was granted and assigned to Xenon Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Xenon Pharmaceuticals
Xenon Pharmaceuticals
0
Current Assignee
Xenon Pharmaceuticals
Xenon Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96309290
Patent Inventor Names
Qi Jia0
Zaihui Zhang0
Shaoyi Sun0
Alla Yurevna Zenova0
Mikhail Chafeev0
Renata Marcella Oballa0
Date of Patent
April 25, 2017
0
Patent Application Number
143555520
Date Filed
October 30, 2012
0
Patent Primary Examiner
‌
Celia Chang
0
Patent abstract

This invention is directed to benzensulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of sodium channel-mediated diseases or conditions, such as pain.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9630929 Benzenesulfonamide compounds and their use as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us